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The volume 21 of the Annual Review of Immunology offers a broad updated
information on selected topics in Basic Immunology for students and researchers.
In 2003, the important area of Immunology of Infectious Diseases and
Vaccines is covered in three chapters. CD8 T cells respond to viral infections
but also participate in defense against bacterial and protozoan infections. Some
viruses, such as influenza virus, cause acute infections and are eliminated. In
contrast, herpes viruses cause latent infections and remain with the host for life.
CD8 T cells play distinct roles in these two circumstances. Bacterial and
protozoan pathogens also cause acute and chronic infections, with similar
challenges for CD8 T cell-mediated immune defense. In the first chapter in this
volume of Annual Review of Immunology, P. WONG & E.G. PAMER summarize
recent knowledge of CD8T cell immunity to pathogens, as learned from the
major mouse models of infectious disease. Viral, bacterial, and protozoan
pathogens that have been used in mouse models to characterize CD8T cell
responses are reviewed. Finally, new concepts of CD8T cell-mediated anti-
microbial immunity that have emerged from these studies are discussed. Viruses
and other invading pathogens have exerted unrelenting selection pressure upon
the mammalian host, necessitating the development of a complex and adaptable
immune system. Large DNA viruses such as herpesviruses and poxviruses provide
some of the most extensive inventories of gene products that serve to defend
these viruses against the assault executed by the host immune response. In an
excellent review, B.T. SEET et al. highlight the many strategies that poxviruses
utilize to modulate key components of the innate and acquired immune responses.
Immunological memory is the basis for protective vaccines. Successful vaccines
have been those that can imitate the generation of neutralizing or opsonizing
antibodies responses that seem to be the only limiting factor against acutely
cytopathic agents. In contrast, cell-mediated immunity against infections that
persist in the host is much more difficult to imitate. In a didactic and informative
review, R.M. ZINKERNAGEL summarizes the general parameters of cell- and
antibody-mediated immune protection and the basic mechanisms responsible
for what we call immunological memory. In his excellent chapter, the author
considers some important questions: Have artificial vaccines been “foreseen”
by nature? What is the physiological equivalent of our vaccines? What is missing
in our knowledge not only about immunity but also about vaccines?
Much information can be obtained on the field of Lymphocyte Surface
Antigens and Activation Mechanisms. As pointed out by M.L. HERMISTON
et al., CD45 was first reviewed by Matt Thomas in 1989 and again by Trowbridge
& Thomas in 1994. Our knowledge concerning CD45 has grown significantly
during the past eight years. In a very up-to-date chapter, the authors review
progress made in keys areas of CD45 biology: structure, regulation of gene
expression and alternative splicing, CD45 function in immune cells, and
regulation of phosphatase activity. Significant associations that have been
reported for autoimmunity, immunodeficiency, malignancy, and perturbations
of CD45 function were also discussed. The IgA receptor family comprises a
number of five surface receptors including the polymeric Ig receptor involved
in epithelial transport of IgA/IgM, the myeloid specific IgA receptor (FcαRI or
CD89), the Fcα/µR, and at least two alternative IgA receptors. These receptors
for IgA play a significant role in vivo in maintaining the integrity of immune
responses in systemic and mucosal compartments. In an interesting chapter,
R.C. MONTEIRO & J.G.J. van de WINKEL summarize the current knowledge
of 5 types of IgA receptors, focusing on CD89. Recent studies supporting a role
for IgA antibodies and FcαRI-directed molecules as therapeutics for human
diseases are also discussed. Over the past several years, significant advances
have been made in elucidating the molecular details of the biochemical cascades
triggered by ligand-engagement of immune cell signaling receptors. A key
organizing element for signaling receptors appears to be cholesterol- and
sphingolipid- rich plasma membrane microdomains termed lipid rafts. M.
DYKSTRA et al. review evidence that lipid rafts play a role in the regulation of
immune cell activation. Over the last years, considerable progress has been made
in characterizing and understanding the mechanisms underlying antigen
recognition by T cells. P.A. van der MERWE & S.J. DAVIS review recent progress
in this area such as: interaction between T cells antigen receptor (TCR) and
processed antigen presented on MHC molecules; CD8 and CD4 co-receptor
molecules; CD28 and CTLA-4 molecules and their ligands B7-1 and B7-2
expressed on antigen-presenting cells; and, interactions between CD2 and its
related ligands.
The area of Lymphocyte Development and Differentiation has been the
target for several reviews in previous volumes of this scientific series.
Homeostasis and normal functioning of the immune system require regulation
of the survival of leukocytes. The death of superfluous, defective, damaged, or
dangerous cells occurs by apoptosis that can be induced by death receptor ligation
or via Bcl-2-inhibitable pathways. In a very interesting chapter, V.S. MARSDEN
& A. STRASSER first focus on the role of the Bcl-2 protein family in the control
of lymphoid and myeloid cell survival; next, the authors discuss as defects in
apoptosis can contribute to autoimmunity, leukemogenesis, and infection. T
cells arise from hematopoietic stem cells and their development occurs in the
thymus and requires signals from nonhematopoietic stromal cells including
various types of thymic epithelial cells and mesenchymal fibroblasts. Positive
and negative selection of T cells occurs predominantly in the thymus, were
lymphocyte precursors first assemble a surface receptor. The current state of the
field regarding the natural ligands and molecular factors required for positive
and negative selection is summarized by T.K. STARR et al. in a very interesting
chapter. The authors also focus on recent data on central tolerance, where it
appears that both dominant (T regulatory cell generation) and recessive (clonal
delection) mechanisms operate in the thymus. The recognition of the polarized
T helper cell subsets Th1 and Th2 has led to an understanding of the role of
these cells in coordinate a variety of immune responses, both in responses to
pathogens and in autoimmune and allergic disease. The immune system has
evolved a magnitude of signal transduction pathways involved in the development
of a Th1 or Th2 response. Excellent reviews on Th2 development and the signal
transduction pathways and transcription factors involved in Th2 differentiation
were subjects in previous volumes of Annual Review of Immunology series. In
this volume, S.J. SZABO et al. focus on the signaling pathways and transcription
factors implicated in Th1 induction, differentiation, and commitment in vitro
and in vivo. Considerable attention is given to the newly identified Th1-inducing
cytokines/cytokine receptors IL-23, IL-27, TCCR/WSX-1, and the novel Th1-
specific transcription factors T-bet and H1x. Recent advances in understanding
the biological nature of hematopoietic stem cells and progenitor cells that have
broadened the potential application of these cells in the treatment of diseases
such as breast cancer, leukemias, and congenital immunodeficiencies are focused
by M. KONDO et al. B Cell chronic lymphocytic leukemia (B-CLL) is defined
as a proliferation of B lymphocytes that express CD19 or CD20, CD5, CD23,
and low levels of IgE and CD79b and CD22 on their surface membranes. In an
extensive review, N. CHIORAZZI & M. FERRARINI discuss the cellular origin
of B-CLL cells, several aspects of the B cell antigen receptor (BCR) of the
leukemia cells, and how the BCR influences the evolution of the leukemic cells
from a normal B cell to a clinically manifested B -CLL clone. Finally, K.L.
BOOK REVIEW*
ANNUAL REVIEW OF IMMUNOLOGY, vol. 21, 2003; edited by William E. PAUL, C. Garrison FATHMAN & Laurie H. GLIMCHER. Palo
Alto, Annual Reviews Inc., 2003. 955 p. ilust. ISBN: 0-8243-3021-8. ISSN 0732-0582.
344
Rev. Inst. Med. trop. S. Paulo
45(6):343-344, November-December, 2003
CALAME et al. review recent work that provides new insights into the
transcriptional regulatory mechanisms that are involved in commitment to
terminal B-cell differentiation and expression of the plasma cell phenotype.
Two chapters deal with TOLERANCE in a very exciting manner. In his
chapter, R.H. SCHWARTZ first introduces a new concept for T cell anergy, that
is defined by the author as a tolerance mechanism in which the lymphocyte is
intrinsically functionally inactivated following an antigen encounter, but remains
alive for an extended period of time in the hyporresponsive state. Then, the
author focuses on the basic types of T cell anergy that fall into two broad
categories. One, clonal anergy, is principally a growth arrest state, whereas the
other, adaptive tolerance or in vivo anergy, represents a more generalized
inhibition of proliferation and effector functions. As pointed out by R.M.
STEINMAN et al., the subject of their interesting review, the role of dendritic
cells (DCs) in T cell tolerance, may be surprising. The authors discuss, in a very
didactic way, several challenging questions related to DCs as tolerogenic cells,
such as: how is possible to use low doses of intact antigens to induce tolerance
in vivo? when DCs are maturing in response to an infection, how do they avoid
the risk of inducing autoimmunity to self-antigens and chronic reactivity to
environmental proteins? can antigen-specific tolerance be induced in clinical
settings, such as transplantation, allergy, and autoimmunity? how are the many
known mechanisms for T cell tolerance engaged and controlled in the intact
animal and patients? Finally, examples in which antigen presentation via DCs
lead to the control of specific tolerance mechanisms in vivo are also reviewed.
The important area of REGULATION OF THE IMMUNE RESPONSE is
covered in three chapters. A novel lymphocyte lineage, Vα14 natural killer T
(NKT) cells, is now well established as distinct from conventional αβT cells. In a
very up-to-date review, M. TANIGUCHI et al. summarize characteristic features
of Vα14 natural killer T cells and discuss the remarkable functional diversity of
these kind of T cells in various immune responses such as host defense by mediating
anti-nonself innate immune reaction, homeostatic regulation of anti-self responses,
and anti-tumor immunity. Innate immune defense is less sophisticated than adaptive
defense. It includes the epithelial surfaces with mechanical barriers and digestive
enzymes, but when microbes penetrate the body, defensive systems capable of
distinguishing pathogens from self-structures are required. The Toll-like receptors
(TLRs) are primordial structures that recognize the pathogen-associated molecular
patterns and are found in insects as well as mammals. In drosophila antimicrobial
responses rely on two signaling pathways: the Toll pathway and the IMD (immune
deficiency) pathway. In mammals there are at least 10 members of the TLR family
that recognize specific patterns of microbial components and regulates the activation
of both innate and adaptive immunity. In a very interesting review, K. TAKEDA
et al. focus on recent progress regarding the functions of TLRs and their signaling
pathways. Collectins (mannan-binding-lectin–MBL, and surfactants proteins A
and D) and ficolins (L-ficolin, M-ficolin, and H-ficolin), present in plasma and on
mucosal surfaces, are humoral molecules which also recognize pathogen-associated
molecular patterns. Upon recognition of the infectious agent, the human collectins
as well as ficolins, initiate the lectin pathway of complement activation through
attached serine proteases. By other hand, surfactant proteins A and D act through
other effector mechanisms: direct opsonization, neutralization, and agglutination.
In an excellent chapter, structure, function, clinical implications, and phylogeny
of human collectins and ficolins, as well as their role in innate immune defense,
are reviewed by V. HOLMSKOV et al.
Two important chapters focus on CYTOKINES. The control of cell survive
is believed to involve regulation of the anti-apoptotic machinery. A factor called
BAFF was recently discovered that is clearly a survival factor for most B cells.
APRIL is a second molecule related to BAFF and shares some of the BAFF
receptor yet appears to play a different biological role. F. MACKAY et al. focus
on recent progress on the survival aspect of BAFF and its receptor interactions
as it applies to B cell biology and to other TNF family members. IL-13 was
originally described as a T cell-derived cytokine that inhibits inflammatory
cytokine production. IL-13 was also thought to be functionally redundant with
IL-4. Over last years, knockout animals were instrumental in demonstrating
non-redundant roles for IL-13. In this context, T.A. WINN highlights important
effector functions mediated by IL-13 and summarizes diverse array of biological
activities including: regulation of intracellular parasitism; gastrointestinal parasite
expulsion; inflammatory diseases of the lung; cancer; tissue remodeling and
fibrosis; finally, regulation and suppression of IL-13 mediated effector function
are discussed.
The hallmark of HIV-1 infection is the progressive depletion of CD4+ T
cells. Yet the extent and nature of this depletion, and the mechanisms by which
it arises, remain highly controversial. In the absence of antiretroviral treatment,
HIV-1 replication is extensive throughout the course of infection, while
deterioration of conventional measures of immunity is slow, including the
characteristic loss of CD4+ T cells that is thought to play a key role in the
development of immunodeficiency. D.C. DOUEK et al. examines HIV-1 infection
from the perspective of lymphocyte dynamics, linking recent empirical and
conceptual advances in HIV-1 biology with new insights into T cell dynamics
to provide an immunological view of the pathogenesis of this infection. In a
very interesting opinion, the authors suggest that profound memory CD4+ T
cells destruction occurring during the acute phase may have a crucial impact on
the subsequent course of the infection.
Given the number of neoantigens expressed by tumors, a central question
in cancer immunology is whether recognition of tumor antigens by the immune
system leads to activation (surveillance) or tolerance. As discussed by D.
PARDOLL in his excellent review. Does the immune system see tumors as foreign
or self? these apparently disparate views can in fact be reconciled into a unified
hypothesis in which tumors must develop specific mechanisms to locally inhibit
the activation of innate and adaptive immunity to progress successfully through
invasive and metastatic stages.
The MHC-encoded proteins are highly polymorphic proteins that constitute
the major barrier for allogenic transplantation and are associated to hundred of
diseases. The MHC was first discovered in mouse and much of our knowledge
about it comes from this mammalian animal model. Available data that can help
us to understand the fundamentals of the MHC are summarized by A.
KUMÁNOVICS et al. In a very interesting review, the authors use the human
and mouse sequences as a guide for comparative analyses of organization and
origin of this crucial part of the immune system.
The reaction of IgE with its receptors is central to the phenomenon of allergy.
An allergic reaction is initiated when an antigen crosslinks immunoglobulin E
(IgE) antibodies bound to their high-affinity Fc receptor (FcεRI) on tissue mast
cells or blood basophils. H. J. GOULD et al. first review recent compelling
evidence that the microenvironment in allergic disease favors class switching to
IgE in preference to IgG in mucosal tissues; then, they discuss how the high
affinity of IgE to mast cell-surface receptors can now be interpreted in terms of
the recently determined crystal structures of IgE- FcεRI and IgG-FcγR complexes.
Finally, in his prefatory chapter The Meandering 45-Year Odyssey of a
Clinical Immunologist, Thomas A. WALDMANN focuses on the cytokines
IL-2 and IL-15, which have competitive functions in adaptive immune responses,
and on new forms of therapy directed at IL-2 and IL-15 receptors against certain
neoplasic diseases and autoimmune disorders and in prevention of allograft
rejection.
The tradition of the series Annual Review of Immunology is to present the
state of the art in different fields of Immunology. Like other volumes, this book
is mostly target to posgraduates and researchers who wish bring themselves up
to date on Basic Immunology.
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